Friday, January 10, 2025

Markets Daily: Good news on jobs might be bad for stocks

The jobs report at 8:30 a.m. New York time will set the tone for trading today. A stronger-than-expected reading would add to concerns that
View in browser
Bloomberg
Markets Snapshot
S&P 500 Futures 5,945.25 -0.23%
Nasdaq 100 Futures 21,296.5 -0.30%
US 10-Year Treasury Yield 4.698% +0.008
Pound 1.23 -0.06%
China's CSI 300 Index 3,732.48 -1.25%
Market data as of 05:46 am EST. View or Create your Watchlist
Market data may be delayed depending on provider agreements.

Five things you need to know

  • The jobs report at 8:30 a.m. New York time will set the tone for trading today. A stronger-than-expected reading would add to concerns that the Federal Reserve may not cut interest rates much further given the risk of resurgent inflation. 
  • The pound is slipping further against the dollar and UK bond yields are rising anew as investors show their skepticism about Chancellor Rachel Reeves' budget plans. 
  • Taiwan Semiconductor's quarterly sales topped estimates, reinforcing hopes that the surge in AI hardware spending has further to run. The shares rise 1.4% in US premarket trading.
  • The potential cost for insurers from the Los Angeles wildfires is now expected to surpass $20 billion, according JPMorgan analysts, doubling their estimate from just a day before.
  • Wall Street executives are locking in plans to award traders and dealmakers their biggest bonus increases since the pandemic, with 10% hikes — or more — coming for many desks.

All-important US jobs day 

How important are rate cuts to the bull case on equities? It's a pressing question for investors in risky assets, who've lately struggled to ignore the bond market's agitated reaction to inflation risk.

Key evidence comes in the form of the December US employment report. Economists predict that non-farm payrolls increased by 165,000, based on the median forecast, with the unemployment rate steady at 4.2%. Bloomberg Economics puts the number of new jobs a lot higher -- at 268,000 -- while Nomura Securities cites indicators including hiring surveys and jobless claims in pegging it at 180,000.

In short, blowout jobs data isn't inconceivable, the kind of report that might lead Fed Chair Jerome Powell to put a fork in hopes he will keep lowering rates in 2025. How investors might react to such a print would say a lot about what the future holds for risk assets.

It's been a long time since better-than-expected employment numbers touched off a decline in equity prices, testament to how confident traders became that inflation had been licked. The last time was June, when a since-revised 92,000-jobs beat in payrolls rattled investors looking for a tamer print. Even then, the drop in the S&P 500 was a scant 0.1%

Since then the stock market has behaved pretty much how you'd expect it to when growth was the obsession of choice, going up when data was good. According to Peter Cecchini, director of research at Axonic Capital, there's reason to believe that's changing.

It's a different story in the bond market, where yields on the 10-year Treasury have surged more than a full percentage point since the Fed began cutting rates in September, reaching 4.72% this week amid concern of resurgent inflation. Given the speed of that rise, strong data will hurt the market less than weak data will help it, some investors and strategists say.

Stocks, though, have rallied even as yields have jumped. Anything above 200,000 new jobs and the S&P 500 Index is seen dropping about 1%, according to Goldman Sachs. A JPMorgan Chase trading desk note sees the gauge poised to fall 0.5% to 1% if the print is above 220,000.

"As we continue to creep towards 5% on the 10-year yield, the reflexive reaction for equities on any strong growth/employment data prints becomes increasingly negative, especially given how stretched valuations have been," said Cecchini. "Equities are pricing in near perfection," but "'inflation has been far stickier than the Fed admits."

Good news has been good news for a while now. The possibility of it becoming bad news again for stock investors is going up. —Denitsa Tsekova, Liz Capo McCormick and Jan-Patrick Barnert 

On the move

Edison International shares fall on concern that the company's Southern California electric utility may have played a role in sparking some of the deadly Los Angeles fires. 

No agency has so far suggested that the utility's facilities were involved, the company said. The stock, which dropped about 10% Wednesday, was down 2.4% in premarket trading.

  • Insurance-related stocks, including Allstate, Travelers, AIG and Chubb, are also retreating as the potential cost of the devastation mounts.
  • Also today, watch for earnings from Walgreens, Delta Air Lines and Corona beer importer Constellation Brands before the market opens. —Subrat Patnaik 

Crypto convert

Donald Trump's conversion from crypto skeptic to cheerleader, and subsequent election win, has lit a fire under digital currencies, with Bitcoin soaring to a record high above $108,000 in December. 

The prominent crypto boosters who backed him financially now are looking forward to a friendlier regulatory environment, with lower risk of SEC enforcement actions.

Click here for Bloomberg's documentary on how Trump learned to love crypto.

Still, the frenzy has lost momentum: Bitcoin is now trading below $95,000, and on Wednesday investors withdrew a net $583 million from US Bitcoin ETFs, the second highest outflow from the group since they debuted a year ago. —Monique Mulima

Alzheimer's hopes

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for Alzheimer's disease in 2025, with data due from several clinical trials.

Companies including Biogen and Eli Lilly have spent billions of dollars developing potential treatments, while others including Novo Nordisk and Roche are also investigating the brain-destroying disease. Bloomberg Intelligence estimates the market for Alzheimer's drugs could reach $13 billion by 2030.

Buyer beware: It's been notoriously difficult to develop drugs to treat Alzheimer's, with dozens of experimental treatments failing in clinical trials over the years. —Lisa Pham

What else we're reading

Please share your thoughts on how we're doing and what we're missing. Contact us at marketsdaily@bloomberg.net.

Enjoying Markets Daily? You might also like:

  • Breaking News Alerts for the biggest stories from around the world, delivered to your inbox as they happen
  • Odd Lots for Joe Weisenthal and Tracy Alloway's daily newsletter on the newest market crazes
  • The Everything Risk for Ed Harrison's weekly take on what could upend markets
  • Money Stuff for Bloomberg Opinion's Matt Levine's newsletter on all things Wall Street and finance
  • Points of Return for Bloomberg Opinion's John Authers' daily dive into markets

Bloomberg.com subscribers have exclusive access to all of our premium newsletters.

Follow Us

Like getting this newsletter? Subscribe to Bloomberg.com for unlimited access to trusted, data-driven journalism and subscriber-only insights.

Before it's here, it's on the Bloomberg Terminal. Find out more about how the Terminal delivers information and analysis that financial professionals can't find anywhere else.  Learn more.

Want to sponsor this newsletter? Get in touch here.

You received this message because you are subscribed to Bloomberg's Markets Daily newsletter. If a friend forwarded you this message, sign up here to get it in your inbox.
Unsubscribe
Bloomberg.com
Contact Us
Bloomberg L.P.
731 Lexington Avenue,
New York, NY 10022
Ads Powered By Liveintent Ad Choices

No comments:

Post a Comment

Jumping on the data center bandwagon

AI spending boom isn't over yet View in browser Industrial Strength is now...